title: The diagnosis and clinical management of the neuropsychiatric manifestations of lupus.
abstract: Neuropsychiatric (NP) involvement in Systemic Lupus Erythematosus (SLE), can be a severe and troubling manifestation of the disease that heavily impacts patient's health, quality of life and disease outcome. It is one of the most complex expressions of SLE which can affect central, peripheral and autonomous nervous system. Complex interrelated pathogenetic mechanisms, including genetic factors, vasculopathy, vascular occlusion, neuroendocrine-immune imbalance, tissue and neuronal damage mediated by autoantibodies, inflammatory mediators, blood brain barrier dysfunction and direct neuronal cell death can be all involved. About NPSLE a number of issues are still matter of debate: from classification and burden of NPSLE to attribution and diagnosis. The role of neuroimaging and new methods of investigation still remain pivotal and rapidly evolving as well as is the increasing knowledge in the pathogenesis. Overall, two main pathogenetic pathways have been recognized yielding different clinical phenotypes: a predominant ischemic-vascular one involving large and small blood vessels, mediated by aPL, immune complexes and leuko-agglutination which it is manifested with more frequent focal NP clinical pictures and a predominantly inflammatory-neurotoxic one mediated by complement activation, increased permeability of the BBB, intrathecal migration of autoantibodies, local production of immune complexes and pro-inflammatory cytokines and other inflammatory mediators usually appearing as diffuse NP manifestations. In the attempt to depict a journey throughout NPSLE from diagnosis to a reasoned therapeutic approach, classification, epidemiology, attribution, risk factors, diagnostic challenges, neuroimaging techniques and pathogenesis will be considered in this narrative review based on the most relevant and recent published data.
authors.affiliation: Department of Medical Sciences, Rheumatology Unit, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy. Electronic address: gvl@unife.it.
authors.forename: M
authors.initials: M
authors.lastname: Govoni
authors.affiliation: Department of Medical Sciences, Rheumatology Unit, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Bortoluzzi
authors.affiliation: Department of Medical Sciences, Rheumatology Unit, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Padovan
authors.affiliation: Department of Medical Sciences, Rheumatology Unit, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Silvagni
authors.affiliation: Neuroradiology Unit, Department of Neuroscience and Rehabilitation, Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Borrelli
authors.affiliation: Neuroradiology Unit, Department of Neuroscience and Rehabilitation, Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Donelli
authors.affiliation: Neuroradiology Unit, Department of Neuroscience and Rehabilitation, Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Ceruti
authors.affiliation: Department of Medical Sciences, Rheumatology Unit, University of Ferrara and Azienda Ospedaliero-Universitaria Sant'Anna, Cona, Ferrara, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Trotta
mesh_terms: D015415:Biomarkers; D019468:Disease Management; D004569:Electroencephalography; D006801:Humans; D020945:Lupus Vasculitis, Central Nervous System / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D064847:Multimodal Imaging / Q000379:methods; D059906:Neuroimaging / Q000379:methods; D009483:Neuropsychological Tests; D012307:Risk Factors
chemical_list: D015415:Biomarkers
keywords: Central and peripheral nervous system; Neuroimaging; Neuropsychiatric lupus; Systemic Lupus Erythematosus